How CHIP and BAG5 Interact to Regulate Alpha-Synuclein in Parkinson's Disease
Author Information
Author(s): Kalia Lorraine V., Kalia Suneil K., Chau Hien, Lozano Andres M., Hyman Bradley T., McLean Pamela J.
Primary Institution: Massachusetts General Hospital, Harvard Medical School
Hypothesis
Does BAG5 inhibit the ubiquitinylation of alpha-synuclein by CHIP?
Conclusion
The study identifies CHIP as an E3 ubiquitin ligase for alpha-synuclein and shows that BAG5 inhibits this process, potentially affecting alpha-synuclein oligomerization.
Supporting Evidence
- CHIP was shown to ubiquitinylate alpha-synuclein, reducing its oligomerization.
- BAG5 was found to inhibit the ubiquitinylation of alpha-synuclein by CHIP.
- Co-immunoprecipitation experiments demonstrated the interaction between CHIP, BAG5, and alpha-synuclein.
- Luciferase-based assays indicated that BAG5 mitigates the ability of CHIP to reduce alpha-synuclein oligomers.
Takeaway
This study shows that a protein called CHIP helps tag another protein, alpha-synuclein, for recycling in cells, but another protein, BAG5, can stop this from happening, which might be important in diseases like Parkinson's.
Methodology
The study used a combination of in vitro assays, co-immunoprecipitation, and luciferase-based protein-fragment complementation assays to investigate the interactions and effects of CHIP and BAG5 on alpha-synuclein.
Limitations
The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website